Schizophrenia Clinical Trial
Official title:
Effects of Aerobic High Intensity Training on Symptoms, Cognition, Cortical Structure, Substance Use and Metabolic Indices in Patients With Schizophrenia Spectrum Disorder
Physical health problems are common in schizophrenia with a two- to three-fold increased
morbidity and mortality rate, resulting in a 20 years reduction in life expectancy. A genetic
vulnerability for developing cardiovascular disease has been documented in these patients,
and many lifestyle factors also negatively influence physical health. Patients with
schizophrenia are likely to smoke, are physically inactive and overweight, suffer from
malnutrition due to unhealthy diet, and have reduced cardiorespiratory fitness. Moreover,
these patients have increased risk of developing diabetes mellitus type II and metabolic
syndrome. These aspects demonstrate the need for multi-disciplinary treatments of patients
with schizophrenia and underline the need for addressing their physical health.
Poor physical fitness seems to be associated with exacerbated negative symptoms and increased
cognitive dysfunction in patients with schizophrenia. However, evidence on physical activity
and its consequences in schizophrenia is scarce. In this randomized controlled trial we
investigate the effects of high intensity training in outpatients with schizophrenia on
psychotic symptoms and well-being, cognition and cortical structure, tobacco smoking and
substance use, in addition to metabolic indices.
Outpatients in treatment will be recruited in this randomized controlled trial (RCT). The
patients will be randomized to either a Computer gaming Skills Group (CSG) or to a physical
Exercise Group (EG). The groups are identically organized in two locations. The interventions
last for 12 weeks, and treatment as usual will be continued for all patients. Patients will
be assessed when entering the study (after randomization and allocation to one of the
clinical groups), as well as post-treatment and 4 months post-treatment. Thus, the planned
study is prospective with a longitudinal design. It is single blind in the sense that the
assessment of psychiatric symptom level and neurocognitive function will be performed by
research staff blind for group membership. The physiological testing will be performed by
staff involved in training and will not be blinded.
EG participants will perform aerobic high intensity training (HIT) consisting of supervised
walking/running on a treadmill 2 times a week for 12 weeks. Each session will have the
following structure; eight-minute warm-up, followed by four times four minutes intervals with
85-95% of maximum heart rate, with active pauses of three minutes of walking at 70% of
maximum heart rate. The exercise session will end with a five minute cool-down period. HIT
performed as 4 x 4 intervals has been proven feasible and safe among patients with
schizophrenia and in other clinical populations.
Participants in the CSG take part in sessions in the clinic playing computer games (Nintendo
Wii Sports). The time spent with activities in the clinic will be the same in both groups.
When absent from scheduled physical exercise/playing computer games the subjects will be
offered to participate on a following day. If absent for a whole week, the training
period/computer games playing period will be prolonged accordingly.
In this randomized controlled trial we investigate the effects of HIT in outpatients with
schizophrenia on symptoms and well-being, cognition and brain structure, smoking habits and
substance use, as well as metabolic indices.
The participating outpatient clinics are catchment area based and cover a population of 200
000 persons with more than 250 patients in the diagnostic group in treatment at one time.
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT05039489 -
A Study on the Brain Mechanism of cTBS in Improving Medication-resistant Auditory Hallucinations in Schizophrenia
|
N/A | |
Completed |
NCT05321602 -
Study to Evaluate the PK Profiles of LY03010 in Patients With Schizophrenia or Schizoaffective Disorder
|
Phase 1 | |
Completed |
NCT05111548 -
Brain Stimulation and Cognitive Training - Efficacy
|
N/A | |
Completed |
NCT04503954 -
Efficacy of Chronic Disease Self-management Program in People With Schizophrenia
|
N/A | |
Completed |
NCT02831231 -
Pilot Study Comparing Effects of Xanomeline Alone to Xanomeline Plus Trospium
|
Phase 1 | |
Completed |
NCT05517460 -
The Efficacy of Auricular Acupressure on Improving Constipation Among Residents in Community Rehabilitation Center
|
N/A | |
Completed |
NCT03652974 -
Disturbance of Plasma Cytokine Parameters in Clozapine-Resistant Treatment-Refractory Schizophrenia (CTRS) and Their Association With Combination Therapy
|
Phase 4 | |
Recruiting |
NCT04012684 -
rTMS on Mismatch Negativity of Schizophrenia
|
N/A | |
Recruiting |
NCT04481217 -
Cognitive Factors Mediating the Relationship Between Childhood Trauma and Auditory Hallucinations in Schizophrenia
|
N/A | |
Completed |
NCT00212784 -
Efficacy and Safety of Asenapine Using an Active Control in Subjects With Schizophrenia or Schizoaffective Disorder (25517)(P05935)
|
Phase 3 | |
Completed |
NCT04092686 -
A Clinical Trial That Will Study the Efficacy and Safety of an Investigational Drug in Acutely Psychotic People With Schizophrenia
|
Phase 3 | |
Completed |
NCT01914393 -
Pediatric Open-Label Extension Study
|
Phase 3 | |
Recruiting |
NCT03790345 -
Vitamin B6 and B12 in the Treatment of Movement Disorders Induced by Antipsychotics
|
Phase 2/Phase 3 | |
Recruiting |
NCT05956327 -
Insight Into Hippocampal Neuroplasticity in Schizophrenia by Investigating Molecular Pathways During Physical Training
|
N/A | |
Terminated |
NCT03261817 -
A Controlled Study With Remote Web-based Adapted Physical Activity (e-APA) in Psychotic Disorders
|
N/A | |
Terminated |
NCT03209778 -
Involuntary Memories Investigation in Schizophrenia
|
N/A | |
Completed |
NCT02905604 -
Magnetic Stimulation of the Brain in Schizophrenia or Depression
|
N/A | |
Recruiting |
NCT05542212 -
Intra-cortical Inhibition and Cognitive Deficits in Schizophrenia
|
N/A | |
Completed |
NCT04411979 -
Effects of 12 Weeks Walking on Cognitive Function in Schizophrenia
|
N/A | |
Terminated |
NCT03220438 -
TMS Enhancement of Visual Plasticity in Schizophrenia
|
N/A |